SCHEMBL19106194

SCHEMBL19106194

c1ccc(-c2nc(-c3ccc(-c4nc(-c5ccccc5)c5sc6ccccc6c5n4)cc3)nc(-c3ccc4ccccc4c3)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.41
▸ KMT2A Q03164 4/20 0.41
▸ ATM Q13315 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ CYP1A2 P05177 2/20 0.39
▸ TP53 P04637 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ADORA2A P29274 3/20 0.37
▸ ADORA1 P30542 3/20 0.37
▸ TNKS O95271 3/20 0.37
▸ TNKS2 Q9H2K2 3/20 0.37
▸ WHR1 P49842 1/20 0.36
▸ CYP1A1 P04798 1/20 0.34
▸ CYP1B1 Q16678 1/20 0.34
▸ LIMK1 P53667 3/20 0.34
▸ AURKA O14965 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ MAPT P10636 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106197 1.00 MEN1 (0.41) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL16902377 0.97 ADORA2A (0.39) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL16902307 0.94 ADORA2A (0.36) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL16902380 0.94 ADORA2A (0.36) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL18018401 0.92 LIMK1 (0.37) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL16581198 0.92 MEN1 (0.36) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL19106246 0.91 ADORA2A (0.36) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL19106305 0.91 MEN1 (0.48) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL18158403 0.91 MEN1 (0.48) MEN1KMT2AATMALDH1A1KDM4E
SCHEMBL19106203 0.90 ADORA2A (0.35) MEN1KMT2AATMALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback